Sponsor Pipeline

Daishi Tian Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
6
Active Trials
3
Recruiting
2
Disease Areas
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-08-06 NCT07748637 A Clinical Study to Evaluate the Safety and Efficacy of GT802 Injection in the Treatment… Early Phase 1 Not Yet Recruiting
2026-07-20 NCT07714798 Universal STAR-T Cell Injection in Generalized Myasthenia Gravis Phase 1 Not Yet Recruiting
Active Trials by Phase
Phase 1
2
Early Phase 1
4
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT07523100 A Study on the Safety and Tolerability of Universal STAR-T Cell Therapy for Multiple… Multiple Sclerosis (MS) Not Yet Recruiting
NCT07714798 Universal STAR-T Cell Injection in Generalized Myasthenia Gravis Generalized Myasthenia Gravis Not Yet Recruiting
Early Phase 1
NCT07058298 GC012F Injection in the Treatment of Refractory Generalized Myasthenia Gravis(24103) Generalized Myasthenia Gravis (gMG) Recruiting
NCT07086404 GC012F Injection in Refractory Idiopathic Inflammatory Myopathy Idiopathic Inflammatory Myopathy (IIM) Recruiting
NCT07303790 This is an Early Exploratory Study to Assess the Tolerability and Safety of GC012F in… Multiple Sclerosis Recruiting
NCT07748637 A Clinical Study to Evaluate the Safety and Efficacy of GT802 Injection in the Treatment… Multiple Sclerosis (MS) Not Yet Recruiting
Disease Areas
Get alerts when Daishi Tian's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free